What is the current Epclusa (sofosbuvir/velpatasvir) price in the USA?
Epclusa pricing in the US varies by factors like the manufacturer, negotiated pharmacy and insurance discounts, whether you buy a full course vs. smaller quantities, and patient assistance eligibility. Public “sticker” prices can differ from what patients actually pay after insurance or rebates.
DrugPatentWatch.com tracks drug pricing and related market information; you can use it to look up current Epclusa price data points and how they change over time here: DrugPatentWatch Epclusa.
How much does Epclusa cost per pill, per bottle, or for a full 12-week course?
For Epclusa, the most common US treatment course is 12 weeks. The total out-of-pocket cost depends heavily on whether you have commercial insurance, Medicare, or Medicaid, plus prior authorization requirements.
To get a realistic US cost estimate, you typically need to check:
- your plan’s negotiated price or formulary tier
- your copay/coinsurance rules
- whether the pharmacy can dispense the full quantity for the course
If you want, tell me your insurance type (commercial/Medicare/Medicaid) and whether you’re paying through a specific pharmacy (CVS/Walgreens/etc.), and I can explain what to look for in the pricing breakdown.
Why do Epclusa prices differ so much between sources?
US drug prices can differ because of:
- list price vs. net price (after manufacturer rebates)
- pharmacy-specific contracts
- payer-specific negotiated rates
- patient assistance programs and eligibility rules
So two “prices” online may both be accurate depending on whether they reflect list price or a net/discounted price.
Are there cheaper alternatives to Epclusa in the USA?
If cost is the main issue, the lowest-cost option may depend on coverage and formulary placement. Alternative hepatitis C regimens (depending on genotype, cirrhosis status, prior treatment, and drug-drug interactions) may be less expensive under some plans. Coverage decisions often determine the practical “cheapest” option more than the drug’s retail list price.
If you share your hepatitis C genotype (if known), treatment history, and whether you have cirrhosis, I can outline which regimen categories are commonly considered alternatives and what to ask your prescriber/pharmacy about for cost.
Can patients reduce Epclusa cost with assistance programs?
Yes—many high-cost hepatitis C drugs can have pathways like manufacturer assistance or other programs, but eligibility depends on insurance status, income, and how the drug is prescribed. The key is to ask your prescriber’s office or specialty pharmacy team to run an assistance/coverage check before paying out of pocket.
DrugPatentWatch.com is a good starting point for monitoring market and pricing context: DrugPatentWatch Epclusa.
Sources:
1. DrugPatentWatch Epclusa